Why Stage 2 breast cancer patient had to delay her treatment: Lancet study flags poor detection and access to therapies

Reshma’s fight shows how early detection and affordable Herceptin access can turn breast cancer from 50% to 80% survival. Learn about India’s gaps, Lancet findings and NGO solutions.

Read more